Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3539772
Reference Type
Journal Article
Title
Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems
Author(s)
Dong, WY; Körber, M; López Esguerra, V; Bodmeier, R
Year
2006
Is Peer Reviewed?
Yes
Journal
Journal of Controlled Release
ISSN:
0168-3659
EISSN:
1873-4995
Book Title
Journal of Controlled Release
Volume
115
Issue
2
Page Numbers
158-167
Language
English
PMID
16963145
DOI
10.1016/j.jconrel.2006.07.013
Web of Science Id
WOS:000242134300006
URL
https://www.proquest.com/scholarly-journals/stability-poly-d-l-lactide-co-glycolide/docview/68972349/se-2?accountid=171501
Exit
Abstract
In-situ forming drug delivery systems are prepared by dissolving a drug and a biodegradable polymer (poly(D,L-lactide-co-glycolide), PLGA) in a biocompatible organic solvent (In-situ implant, ISI) or further emulsified into an external phase (oil or aqueous solution), resulting in oil-in-oil or oil-in-water emulsions (In-situ forming microparticles, ISM). The chemical stability of PLGA and the drug is a major concern. In this study, the stability of PLGA and leuprolide acetate in the in-situ forming systems and lyophilized sponges was investigated. The degradation of PLGA increased with increasing storage temperature and water content in the biocompatible solvents. A faster degradation occurred in polar protic solvents (2-pyrrolidone, PEG 400, triethyl citrate) than in polar aprotic solvents (N-methyl-2-pyrrolidone, DMSO, triacetin, ethyl acetate). The presence of leuprolide acetate significantly accelerated PLGA degradation, especially in solution state. PLGA was stable in oily suspensions at 4 degrees C and degraded only slightly faster than solid powder at 25 degrees C. No interaction between the oils and the PLGA was observed as indicated by an unchanged T(g) of approx. 47 degrees C. PLGA underwent a slight degradation at 4 degrees C after 150 days in water and saturated sodium chloride solution. The degradation was slower in saturated sodium chloride solution than in water at 25 degrees C. Residual acetic acid in lyophilized sponges facilitated the PLGA degradation in contrast to dioxane. Leuprolide acetate did not affect the PLGA stability negatively. However, lidocaine significantly enhanced the polymer degradation in the sponges. Finally, leuprolide acetate was chemically stable in the sponges, the oils and the polymer solutions in suspension state, but unstable (aggregation) when dissolved in the polymer solutions and stored at 25 degrees C and 40 degrees C.
Keywords
Oils; Polymers; Solvents; 059QF0KO0R; Polylactic Acid-Polyglycolic Acid Copolymer; 1SIA8062RS; Polyglycolic Acid; 26009-03-0; Lactic Acid; 33X04XA5AT; Leuprolide; EFY6W0M8TG; Index Medicus; Temperature; Drug Stability; Freeze Drying; Chromatography, High Pressure Liquid; Nanoparticles; Drug Storage; Differential Thermal Analysis; Humidity; Drug Compounding; Chromatography, Gel; Leuprolide -- pharmacology; Drug Delivery Systems
Tags
OPPT REs
•
OPPT_1,4-Dioxane_D. Exposure
Total – title/abstract screening
Supplemental Search
Consumer Use
•
OPPT_N-methylpyrrolidone (NMP)_F. Human Health
Total – title/abstract screening
Off topic
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity